Zydus Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ETHACRYNIC ACID USP, with a corresponding US DMF Number 25647.
Remarkably, this DMF maintains an Active status since its submission on February 21, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 23, 2014, and payment made on March 27, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II